UC San Diego Health Begins Treating Multiple Myeloma with CAR T-cell Therapy
June 3, 2021
As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month.
Your search for “Cancer Immunotherapy” returned 113 results
Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players
September 20, 2018
…published September 20 in Cell, may help researchers improve cancer immunotherapies and predict which patients will respond best.
New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies
October 17, 2019
…from Canada to Moores Cancer Center at UC San Diego Health every month to receive cancer treatment at the newly established Precision Immunotherapy Clinic. Photo by Yadira Galindo/UC San Diego Health New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies Using a personalized approach, Moores Cancer Center at UC…
Boosting Immune Cell Memory to Improve Vaccines and Cancer Immunotherapy
August 28, 2017
…could be used to improve how well vaccines and immunotherapies work and how long they last.
UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells
April 1, 2019
Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
December 1, 2016
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings could have a clinical role in improving efficiency of immunotherapy drugs.
UC San Diego Cancer Biologist Receives Claugus Award for Medical Research
October 11, 2023
University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.
How Chronic Inflammation Tips the Balance of Immune Cells to Promote Liver Cancer
November 8, 2017
…known to drive many cancers, especially liver cancer. Researchers have long thought that’s because inflammation directly affects cancer cells, stimulating their division and protecting them from cell death. But University of California San Diego School of Medicine researchers have now found that chronic liver inflammation also promotes cancer by suppressing…
Study: Endometrial Cancer Treatment Has Significant Results
March 27, 2023
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health examined a new treatment approach for endometrial cancer.
Inhibiting Enzyme Helps Cancer Immunotherapy Work Better
August 3, 2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live longer.
